首页> 美国卫生研究院文献>Molecular Genetics Genomic Medicine >A risk assessment model of acute liver allograft rejection by genetic polymorphism of CD276
【2h】

A risk assessment model of acute liver allograft rejection by genetic polymorphism of CD276

机译:CD276基因多态性的急性同种异体移植排斥反应的风险评估模型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundLiver transplantation is an effective therapy for end‐stage liver diseases and acute liver failure. After the operation, however, recipients may suffer grafts loss induced by alloimmune reaction, which is termed as acute allograft rejection. The interaction between costimulatory molecules, CD276, and its ligand, TREML2, promotes T cell‐mediated immune response, as well as acute or chronic allograft rejection. Our research aimed at correlating genetic polymorphisms of CD276/TREML2 with acute rejection, and evaluating its prognostic value of acute rejection after liver transplantation.
机译:背景肝移植是晚期肝病和急性肝衰竭的有效疗法。但是,手术后,受体可能会遭受同种免疫反应诱导的移植物丢失,这被称为急性同种异体移植排斥反应。共刺激分子CD276及其配体TREML2之间的相互作用促进了T细胞介导的免疫反应以及同种异体移植的急性或慢性排斥反应。我们的研究旨在将CD276 / TREML2的基因多态性与急性排斥反应相关联,并评估其在肝移植后急性排斥反应的预后价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号